These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 13784893

  • 1. The indications for combined treatment with trifluoperazine and amylobarbitone.
    WHITELEY JS.
    Br J Clin Pract; 1961 Jul; 15():613-5. PubMed ID: 13784893
    [No Abstract] [Full Text] [Related]

  • 2. Trifluoperazine and amylobarbitone in the treatment of psychoneurosis.
    LAZARUS S.
    Appl Ther; 1962 Aug; 4():725-8. PubMed ID: 14463101
    [No Abstract] [Full Text] [Related]

  • 3. The management of neurotic and psychotic states with Ro 5-0690 (librium).
    KINROSS-WRIGHT J, COHEN IM, KNIGHT JA.
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():23-6. PubMed ID: 14409235
    [No Abstract] [Full Text] [Related]

  • 4. Use of trifluoperazine in chronic psychotic patients.
    EXT HJ.
    Dis Nerv Syst; 1960 Mar; 21():154-7. PubMed ID: 13821113
    [No Abstract] [Full Text] [Related]

  • 5. A controlled comparison of methaminodiazepoxide (chlordiazepoxide, "Librium") and amylobarbitone in the treatment of anxiety in neurotic patients.
    JENNER FA, KERRY BJ, PARKIN D.
    J Ment Sci; 1961 May; 107():583-9. PubMed ID: 13789850
    [No Abstract] [Full Text] [Related]

  • 6. A clinical trial study of trifluoperazine.
    KATERYNIUK N, MORRIS CW.
    Dis Nerv Syst; 1961 Nov; 22():639-41. PubMed ID: 14454236
    [No Abstract] [Full Text] [Related]

  • 7. Use of trifluoperazine and discharge planning procedures in psychotic patients.
    SPICER ER, GYSIN WM.
    Nebr State Med J; 1960 Jun; 45():313-5. PubMed ID: 13833303
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical effects of dixyrazine on neurotic and psychotic depressive states].
    FOUKS.
    Acta Neurol Psychiatr Belg; 1961 Aug; 61():727-33. PubMed ID: 13894277
    [No Abstract] [Full Text] [Related]

  • 10. Broad spectrum treatment of the neurotic and the borderline psychotic patient in office practice.
    MORIARTY JD.
    J Neuropsychiatr; 1959 Aug; 1():112-7. PubMed ID: 14424159
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of psychoneurotic conditions with trifluoperazine.
    BRAM G.
    Br J Clin Pract; 1960 Feb; 14():107-9. PubMed ID: 13803809
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Some interpersonal processes and situations delaying discharge from a psychiatric institute.
    MURPHY BW.
    Dis Nerv Syst; 1951 Sep; 12(9):273-7. PubMed ID: 14887567
    [No Abstract] [Full Text] [Related]

  • 16. Use of tranquilizing agents in psychoses and neuroses.
    HOCH PH.
    Med Clin North Am; 1958 May; 42(3):781-9. PubMed ID: 13540542
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of psychoneurotic conditions with long acting trifluoperazine (stelazine), spansule capsules.
    BRAN G.
    Br J Clin Pract; 1962 Feb; 16():143-5. PubMed ID: 13872445
    [No Abstract] [Full Text] [Related]

  • 18. [Trials with azacon in mental hospital patients].
    UDDENBERG CE, LUNDGREN B.
    Sven Lakartidn; 1959 Nov 20; 56():3272-9. PubMed ID: 13840154
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SOME ASPECTS OF ADVANCES IN PSYCHIATRY.
    TAN ES.
    Med J Malaya; 1963 Sep 20; 18():30-7. PubMed ID: 14064294
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.